Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Identification of a Human Airway Epithelial Cell Subpopulation with Altered Biophysical, Molecular, and Metastatic Properties.

Pagano PC, Tran LM, Bendris N, O'Byrne S, Tse HT, Sharma S, Hoech JW, Park SJ, Liclican EL, Jing Z, Li R, Krysan K, Paul MK, Fontebasso Y, Larsen JE, Hakimi S, Seki A, Fishbein MC, Gimzewski JK, Carlo DD, Minna JD, Walser TC, Dubinett SM.

Cancer Prev Res (Phila). 2017 Sep;10(9):514-524. doi: 10.1158/1940-6207.CAPR-16-0335. Epub 2017 Jul 28.

PMID:
28754664
2.

The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome.

Caswell DR, Swanton C.

BMC Med. 2017 Jul 18;15(1):133. doi: 10.1186/s12916-017-0900-y. Review.

3.

Intratumoral Cancer Cell Intravasation Can Occur Independent of Invasion into the Adjacent Stroma.

Deryugina EI, Kiosses WB.

Cell Rep. 2017 Apr 18;19(3):601-616. doi: 10.1016/j.celrep.2017.03.064.

4.

Emerging Biological Principles of Metastasis.

Lambert AW, Pattabiraman DR, Weinberg RA.

Cell. 2017 Feb 9;168(4):670-691. doi: 10.1016/j.cell.2016.11.037. Review.

PMID:
28187288
5.

EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression.

Pradella D, Naro C, Sette C, Ghigna C.

Mol Cancer. 2017 Jan 30;16(1):8. doi: 10.1186/s12943-016-0579-2. Review.

6.

Cancer Tills the Premetastatic Field: Mechanistic Basis and Clinical Implications.

Chin AR, Wang SE.

Clin Cancer Res. 2016 Aug 1;22(15):3725-33. doi: 10.1158/1078-0432.CCR-16-0028. Epub 2016 Jun 1. Review.

7.

Monitoring the Growth of an Orthotopic Tumour Xenograft Model: Multi-Modal Imaging Assessment with Benchtop MRI (1T), High-Field MRI (9.4T), Ultrasound and Bioluminescence.

Ramasawmy R, Johnson SP, Roberts TA, Stuckey DJ, David AL, Pedley RB, Lythgoe MF, Siow B, Walker-Samuel S.

PLoS One. 2016 May 25;11(5):e0156162. doi: 10.1371/journal.pone.0156162. eCollection 2016.

8.

Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells.

Tachtsidis A, McInnes LM, Jacobsen N, Thompson EW, Saunders CM.

Clin Exp Metastasis. 2016 Aug;33(6):521-50. doi: 10.1007/s10585-016-9796-8. Epub 2016 May 17. Review.

9.

The Dark Side of Cell Fusion.

Bastida-Ruiz D, Van Hoesen K, Cohen M.

Int J Mol Sci. 2016 Apr 28;17(5). pii: E638. doi: 10.3390/ijms17050638. Review.

10.

A hypoxic signature marks tumors formed by disseminated tumor cells in the BALB-neuT mammary cancer model.

Msaki A, Pastò A, Curtarello M, Arigoni M, Barutello G, Calogero RA, Macagno M, Cavallo F, Amadori A, Indraccolo S.

Oncotarget. 2016 May 31;7(22):33081-95. doi: 10.18632/oncotarget.8859.

11.

Learning about the Importance of Mutation Prevention from Curable Cancers and Benign Tumors.

Wang G, Chen L, Yu B, Zellmer L, Xu N, Liao DJ.

J Cancer. 2016 Jan 28;7(4):436-45. doi: 10.7150/jca.13832. eCollection 2016. Review.

12.

Alpha fetoprotein plays a critical role in promoting metastasis of hepatocellular carcinoma cells.

Lu Y, Zhu M, Li W, Lin B, Dong X, Chen Y, Xie X, Guo J, Li M.

J Cell Mol Med. 2016 Mar;20(3):549-58. doi: 10.1111/jcmm.12745. Epub 2016 Jan 12.

13.

Surviving at a distance: organ specific metastasis.

Obenauf AC, Massagué J.

Trends Cancer. 2015 Sep 1;1(1):76-91.

14.

Cancer Metastases: Early Dissemination and Late Recurrences.

Friberg S, Nyström A.

Cancer Growth Metastasis. 2015 Nov 29;8:43-9. doi: 10.4137/CGM.S31244. eCollection 2015. Review.

15.

Mathematical Modelling of Molecular Pathways Enabling Tumour Cell Invasion and Migration.

Cohen DP, Martignetti L, Robine S, Barillot E, Zinovyev A, Calzone L.

PLoS Comput Biol. 2015 Nov 3;11(11):e1004571. doi: 10.1371/journal.pcbi.1004571. eCollection 2015 Nov.

16.

Targeting Breast Cancer Metastasis.

Jin X, Mu P.

Breast Cancer (Auckl). 2015 Sep 1;9(Suppl 1):23-34. doi: 10.4137/BCBCR.S25460. eCollection 2015. Review.

17.

A novel microfluidic platform for studying mammalian cell chemotaxis in different oxygen environments under zero-flow conditions.

Yang W, Luo C, Lai L, Ouyang Q.

Biomicrofluidics. 2015 Aug 24;9(4):044121. doi: 10.1063/1.4929406. eCollection 2015 Jul.

18.

Bioresponsive antisense DNA gold nanobeacons as a hybrid in vivo theranostics platform for the inhibition of cancer cells and metastasis.

Bao C, Conde J, Curtin J, Artzi N, Tian F, Cui D.

Sci Rep. 2015 Jul 20;5:12297. doi: 10.1038/srep12297.

19.

Presence of pancreatic intraepithelial neoplasia-3 in a background of chronic pancreatitis in pancreatic cancer patients.

Hwang IK, Kim H, Lee YS, Kim J, Cho JY, Yoon YS, Han HS, Hwang JH.

Cancer Sci. 2015 Oct;106(10):1408-13. doi: 10.1111/cas.12744. Epub 2015 Sep 4.

20.

Supplemental Content

Support Center